http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6455051-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
filingDate | 1998-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f65abde6b505f43e2779cebfaa704e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_188286a15d1cee99c8f8e0c3fb80597d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e29eced3147c69841af0f3662f84239 |
publicationDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-6455051-B1 |
titleOfInvention | Ameliorant for hepatitis C therapeutic effect and application thereof |
abstract | The present invention provides an ameliorant for enhancing the therapeutic effect of IFN-alpha on hepatitis C; a therapeutic composition for the treatment of hepatitis C which comprises IFN-alpha and IFN-gamma as active ingredients and further contains a pharmaceutically acceptable carrier; a kit for the treatment of hepatitis C which comprises an IFN-alpha preparation and an IFN-gamma preparation; and a therapeutic method for the treatment of hepatitis C which comprises administering IFN-alpha and IFN-gamma to a subject at the same time or administering IFN-gamma before the administration of IFN-alpha. The present invention is capable of making the patient continuously HCV-RNA negative and is extremely useful in the treatment of chronic hepatitis C which is intractable with, IFN-alpha and conventionally difficult to remedy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03030923-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005013801-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004078207-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009196853-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018875-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005095224-A1 |
priorityDate | 1997-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.